In cystic fibrosis, a pulmonary disease caused by mutations in the ABC transporter cystic fibrosis transmembrane conductance regulator (CFTR, ABCC7),15, 16 compounds have successfully been developed, which partially or completely correct the molecular defect in a mutation‐specific manner. The gene discussed is CFTR; the disease is cystic fibrosis.